The global demand for Thrombectomy Devices Market is presumed to reach the market size of nearly USD 5.11 BN by 2030 from USD 2.7 BN in 2022 with a CAGR of 8.3% under the study period 2023 - 2030.
Thrombectomy devices are medical devices used to remove blood clots from arteries and veins in the body. These devices are used to treat conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), stroke, and peripheral arterial disease (PAD). Thrombectomy devices work by mechanically or chemically breaking up blood clots and removing them from the affected blood vessels. Mechanical thrombectomy devices use a variety of techniques, such as suction, stent retrievers, and catheters, to physically remove the clot. Chemical thrombectomy devices, on the other hand, use drugs to dissolve the clot. Thrombectomy devices are available in a variety of sizes and configurations to meet the specific needs of different patients and conditions. They are typically used in hospitals or other healthcare facilities by trained medical professionals.
Cardiovascular and cerebrovascular diseases, such as deep vein thrombosis (DVT), pulmonary embolism (PE), stroke, and peripheral arterial disease (PAD), are on the rise worldwide. As the incidence of these diseases increases, the demand for thrombectomy devices is expected to grow. New and innovative thrombectomy devices have been invented that are more effective and safer than previous generations. For example, some devices now use mechanical suction instead of manual aspiration, which reduces the risk of complications and improves patient outcomes. As awareness of cardiovascular and cerebrovascular diseases increases, more patients are being diagnosed and treated for these conditions leading to demand for thrombectomy devices as a key treatment option. The ageing of the population is another key driver of the thrombectomy devices market. Growing healthcare expenditure, particularly in emerging economies, is expected to drive demand for thrombectomy devices. As more resources are allocated to healthcare, more patients are able to access advanced treatments, including thrombectomy devices. Reimbursement policies, which vary by country and region, can significantly impact the thrombectomy devices market. As governments and healthcare payers seek to control costs, reimbursement policies may become more restrictive, which could limit access to these devices.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of thrombectomy devices. The growth and trends of thrombectomy devices industry provide a holistic approach to this study.
This section of the thrombectomy devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product Type
- Aspiration Thrombectomy Devices
- Mechanical/Fragmentaion Thrombectomy Devices
- Coil Retrievers
- Basket/Brush Retrievers
- Stent Retrievers
- Rheolytic/Hydrodynamic Thrombectomy Devices
- Ultrasound-Assisted Thrombectomy Devices
By Devices Type
- Cardiovascular Thrombectomy
- Neurovascular Thrombectomy
- Peripheral Vascular Thrombectomy
- Hospitals And Specialty Clinics
- Ambulatory Surgery Centers
This section covers the regional outlook, which accentuates current and future demand for the Thrombectomy Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Thrombectomy Devices Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the thrombectomy devices market include Stryker Corporation, Boston Scientific Corporation, Medtronic plc, Terumo Corporation, Johnson & Johnson, Teleflex Incorporated, Argon Medical Devices Inc, Edwards Lifesciences Corporation,Koninklijke Philips N.V., Penumbra Inc Others. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.